Bio-healthcare company Dx&Vx (DXVX) has accelerated the development program for a universal COVID-19 vacci...
US-based BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has a...
It was a privilege to share BioSpectrum Asia’s vision and editorial focus with AVING News during ICPI Week 2025 in...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
MediThinQ, the South Korean startup specialising in wearable extended reality (XR) surgical displays, has announced a st...
The Ministry of Health and Welfare (MoHW), South Korea government and the National Institute for Korean M...
Thermo Fisher recently celebrated the opening of its new Cell and Gene Therapy (CGT) Vision Centre in South Korea. The c...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
US-based TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and s...
Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with Ubix Therapeutics to accelerate highly tar...
Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade...
Vuno, a leading South Korean medical artificial intelligence (AI) startup, has announced that its flagship AI-powered ca...
South Korea-based International Vaccine Institute (IVI) in collaboration with International Centre for Antimicrobial Res...
South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therapeutics, has...
What criteria were used to select keynote speakers and feature pavilions this year, and what message are you aiming to c...
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cu...
ICPI WEEK 2025, Asia’a leading industrial B2B exhibition, successfully concluded its four-day run at KINTEX (Korea...
US-based AGC Biologics, a global Contract Development and Manufacturing Organisation (CDMO), has announced a multiphase ...
